IRTC

iRhythm Holdings, Inc. IRTC

NasdaqMid CapHealthcare

13F Pro quality score

Rank #1,302 of 2,925TOP 50%

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$224.17M

Quarter to Jun 30

Net income

$-381.0K

Quarter to Jun 30

Free cash flow

$37.52M

Quarter to Jun 30

Operating margin

-1.1%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$4.96B total
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Operating Margin

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/IRTC

Earnings Per Share

13fpro.ai/company/IRTC

Loading ratio trend…

IRTC key financials by period

Reported revenue, net income and operating margin by fiscal year, from iRhythm Holdings, Inc.'s annual filings on SEC EDGAR.

iRhythm Holdings, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$747.1M$-44.6M-7.7%
FY 2024$591.8M$-113.3M-19.5%
FY 2023$492.7M$-123.4M-25.4%
FY 2022$410.9M$-116.2M-27.7%
FY 2021$322.8M$-101.4M-31.0%
FY 2020$265.2M$-43.8M-16.5%
Source: IRTC filings on SEC EDGAR →

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

IRTC insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About iRhythm Holdings, Inc. (IRTC): stock profile, AI score and financials

iRhythm Holdings, Inc. (IRTC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores IRTC at 54.7/100 on a composite quality score built from its SEC filings, placing it at rank #1,302 of 2,925 stocks — the top half of the AI-ranked universe. IRTC scores in the top quartile across earnings quality (97.6), revenue growth (84.0). Areas of concern include balance sheet strength (30.0) and institutional flow (34.9), which score below median versus the broader universe. Shareholder dilution risk is elevated at 14.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), iRhythm Holdings, Inc. reports quarterly revenue of $224.2M, net income of $-381.0K, an operating margin of -1.1%. Top institutional holders of IRTC by reported 13-F value include BlackRock, RTW INVESTMENTS, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. IRTC trades on the Nasdaq exchange and files with the SEC under CIK 1388658. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IRTC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for iRhythm Holdings, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1388658 →